Figure 2

FOSI change from baseline to 6 months for (A) the overall population and patients with (B) BRCA m and (C) g BRCA m. Worsening of FOSI indicated with a negative score. Olaparib/Placebo indicates the number of patients who completed the assessment at each time point. Abbreviations: CI=confidence interval; LSM=least squares mean.